tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CMPX Stock Latest News

Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference
Press ReleasesCompass Therapeutics to Participate in the Jefferies Global Healthcare Conference
2M ago
CMPX
Compass Therapeutics Announces CEO Transition and New Leadership
PremiumCompany Announcements
Compass Therapeutics Announces CEO Transition and New Leadership
2M ago
8K
CMPX
Compass Therapeutics Announces CEO Transition
PremiumPress Releases
Compass Therapeutics Announces CEO Transition
2M ago
CMPX
Compass Therapeutics CEO Vered Bisker-Leib steps down, Thomas Schuetz succeeds
PremiumThe Fly
Compass Therapeutics CEO Vered Bisker-Leib steps down, Thomas Schuetz succeeds
2M ago
CMPX
Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrating Anti-Tumor Activity in Patients Who Have Progressed on Approved PD-1 or PD-L1 Inhibitors at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024
PremiumPress Releases
Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrating Anti-Tumor Activity in Patients Who Have Progressed on Approved PD-1 or PD-L1 Inhibitors at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024
2M ago
CMPX
Compass Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
PremiumPress ReleasesCompass Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
2M ago
CMPX
Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate Update
PremiumPress Releases
Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate Update
3M ago
CMPX
Compass Therapeutics sees cash runway into late 2026
PremiumThe Fly
Compass Therapeutics sees cash runway into late 2026
3M ago
CMPX
Compass Therapeutics reports Q1 EPS (8c), consensus (11c)
PremiumThe Fly
Compass Therapeutics reports Q1 EPS (8c), consensus (11c)
3M ago
CMPX
CMPX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CMPX Upcoming Earnings Report: What to Expect?
3M ago
CMPX
Compass Therapeutics receives FDA FTD for investigation of CTX-009
PremiumThe Fly
Compass Therapeutics receives FDA FTD for investigation of CTX-009
3M ago
CMPX
Compass Therapeutics’ CTX-009 Gains FDA Fast Track Status
PremiumCompany Announcements
Compass Therapeutics’ CTX-009 Gains FDA Fast Track Status
3M ago
8K
CMPX
Compass Therapeutics announces first patient dosed in Phase 1 study of CTX-8371
PremiumThe FlyCompass Therapeutics announces first patient dosed in Phase 1 study of CTX-8371
3M ago
CMPX
Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference
PremiumPress Releases
Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference
4M ago
CMPX
Compass Therapeutics to Participate in the Stifel Targeted Oncology Days
PremiumPress Releases
Compass Therapeutics to Participate in the Stifel Targeted Oncology Days
4M ago
CMPX
Compass Therapeutics presents data on combination of CTX-009, CTX-471
PremiumThe Fly
Compass Therapeutics presents data on combination of CTX-009, CTX-471
4M ago
CMPX
Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting
PremiumPress Releases
Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting
4M ago
CMPX
Compass Therapeutics Reports 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
Compass Therapeutics Reports 2023 Financial Results and Provides Corporate Update
4M ago
CMPX
Compass Therapeutics reports Q4 EPS (11c), consensus (9c)
PremiumThe Fly
Compass Therapeutics reports Q4 EPS (11c), consensus (9c)
4M ago
CMPX
Compass Therapeutics announces publication of CTX-8371 preclinical data
PremiumThe FlyCompass Therapeutics announces publication of CTX-8371 preclinical data
5M ago
CMPX
CMPX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CMPX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
CMPX
Compass Therapeutics Provides Corporate Update
PremiumPress Releases
Compass Therapeutics Provides Corporate Update
7M ago
CMPX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >